
ADAMAS PHARMACEUTICALS INC
Aktie · US00548A1060 · ADMS · A111X7 (XNAS)
Kein Kurs
n/a
Performance
Heute | Woche | Monat | 3 Monate | 6 Monate | 1 Jahr | 5 Jahre |
---|---|---|---|---|---|---|
- | - | - | - | 0,00 % | 0,00 % | 175,84 % |
Firmenprofil zu ADAMAS PHARMACEUTICALS INC Aktie
Adamas Pharmaceuticals, Inc. focuses on the discovery, development, and commercialization of medicines for patients suffering from chronic neurologic disorders in the United States. The company offers GOCOVRI, an extended release capsule for the treatment of dyskinesia in patients with Parkinson's disease receiving levodopa-based therapy, with or without concomitant dopaminergic medications. It is also developing ADS-5102 that is in Phase III clinical study to treat walking impairment in patients with multiple sclerosis and other indications; and ADS-4101, which has completed two Phase I studies for treating partial onset seizures in patients with epilepsy. In addition, the company offers Namzaric (memantine hydrochloride extended release and donepezil hydrochloride) capsules for the treatment of moderate to severe dementia of an Alzheimer's type. The company was formerly known as NeuroMolecular Pharmaceuticals, Inc. and changed its name to Adamas Pharmaceuticals, Inc. in July 2007. Adamas Pharmaceuticals, Inc. was founded in 2000 and is headquartered in Emeryville, California.
Unternehmensdaten
Name ADAMAS PHARMACEUTICALS INC
Firma Adamas Pharmaceuticals, Inc.
Symbol ADMS
Website
http://www.adamaspharma.com
Heimatbörse
NASDAQ

WKN A111X7
ISIN US00548A1060
Wertpapierart Aktie
Sektor Healthcare
Branche Drug Manufacturers - Specialty & Generic
CEO Mr. Neil McFarlane
Land Vereinigte Staaten von Amerika
Währung USD
Mitarbeiter 0,1 T
Adresse 1900 Powell St Ste 1000, 94608 Emeryville
IPO Datum 2014-04-10
Ticker Symbole
Name | Symbol |
---|---|
NASDAQ | ADMS |
Weitere Aktien
Investoren die ADAMAS PHARMACEUTICALS INC die halten, haben auch folgende Aktien im Depot:
Die Finanzplattform MoneyPeak trackt und analysiert Investitionen und Portfolios.
Vom Wertpapier-Depot bis zum Crypto-Kauf.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.